| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8935231 | British Journal of Anaesthesia | 2012 | 9 Pages |
Abstract
We have shown in a range of preparations and assays that UFP-505 behaves as a potent MOP agonist and DOP antagonist; a MOP/DOP bifunctional opioid. Further studies in dual expression systems and whole animals with this prototype are warranted.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
N. Dietis, J. McDonald, S. Molinari, G. Calo, R. Guerrini, D.J. Rowbotham, D.G. Lambert,